Sorli C, Harashima S-I, Tsoukas GM et al (2017) Efficacy and safety of once-weekly semaglutide monotherapy versus placebo in patients with type 2 diabetes (SUSTAIN 1): a double-blind, randomised, placebo-controlled, parallel-group, multinational, multicentre phase 3a trial
If youre losing weight but still lifting similar weights in the gym, thats often a strong signal that you are preserving muscle, and thats exactly what we want
Step 1 - before your treatment, we will undertake a thorough consultation that can be done over the phone or face to face or on the same day as your treatment
They can also help you understand the potential benefits and risks associated with these medications
Indications* Support for heart and muscle health Management of fatigue and migraines Enhancement of athletic performance Does not contain colorants, flavor enhancers, or sweeteners
Saxenda (liraglutide 3.0 mg) is a GLP-1 receptor agonist licensed in the UK for weight management in adults with obesity or overweight with weight-related conditions